Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Intangibles (2022 - 2026)

Sunshine Biopharma filings provide 4 years of Change in Intangibles readings, the most recent being $40998.0 for Q4 2025.

  • On a quarterly basis, Change in Intangibles rose 948.82% to $40998.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $661815.0, a 105.37% increase, with the full-year FY2025 number at $661815.0, up 105.37% from a year prior.
  • Change in Intangibles hit $40998.0 in Q4 2025 for Sunshine Biopharma, up from $26103.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $686044.0 in Q4 2023 to a low of -$402296.0 in Q2 2024.
  • Median Change in Intangibles over the past 4 years was $92519.0 (2024), compared with a mean of $138533.5.
  • The widest YoY moves for Change in Intangibles: up 4185.27% in 2024, down 150.26% in 2024.
  • Sunshine Biopharma's Change in Intangibles stood at $111015.0 in 2022, then soared by 517.97% to $686044.0 in 2023, then crashed by 100.7% to -$4830.0 in 2024, then soared by 948.82% to $40998.0 in 2025.
  • The last three reported values for Change in Intangibles were $40998.0 (Q4 2025), $26103.0 (Q3 2025), and $390187.0 (Q2 2025) per Business Quant data.